Anzeige
Mehr »
Login
Sonntag, 11.04.2021 Börsentäglich über 12.000 News von 660 internationalen Medien
Kurseskalation am Montag? Diese Gamechanger-News macht es möglich!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1C72G ISIN: BMG8162K1137 Ticker-Symbol: TEL1 
Frankfurt
09.04.21
08:02 Uhr
0,216 Euro
-0,002
-0,92 %
Branche
Pharma
Aktienmarkt
ASIEN
1-Jahres-Chart
SIHUAN PHARMACEUTICAL HOLDINGS GROUP LTD Chart 1 Jahr
5-Tage-Chart
SIHUAN PHARMACEUTICAL HOLDINGS GROUP LTD 5-Tage-Chart
RealtimeGeldBriefZeit
0,2220,23217:34
0,2220,23209.04.

Aktuelle News zur SIHUAN PHARMACEUTICAL HOLDINGS GROUP Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
SIHUAN PHARMACEUTICAL HOLDINGS GROUP Aktie jetzt für 0€ handeln
08:43SIHUAN PHARM (00460.HK) Buys Back 3.9M Shrs at $8.08M1
FrSIHUAN PHARM (00460): NEXT DAY DISCLOSURE RETURNS-
FrSIHUAN PHARM (00460): VOLUNTARY ANNOUNCEMENT - SHARE REPURCHASE-
01.04.SIHUAN PHARM (00460): VOLUNTARY ANNOUNCEMENT-SIHUAN PHARMACEUTICAL OBTAINED DRUG REGISTRATION APPROVAL IN RELATION TO AMBROXOL HYDROCHLORIDE INJECTION-
30.03.SIHUAN PHARM (00460): NOTIFICATION LETTER AND REQUEST FORM TO NON-REGISTERED HOLDER1
30.03.SIHUAN PHARM (00460): NOTIFICATION LETTER AND CHANGE REQUEST FORM TO REGISTERED HOLDER-
30.03.SIHUAN PHARM (00460): ANNUAL REPORT 2020-
25.03.SIHUAN PHARM (00460): VOLUNTARY ANNOUNCEMENT SIHUAN PHARMACEUTICAL OBTAINED DRUG REGISTRATION APPROVAL IN RELATION TO RIVAROXABAN TABLETS-
23.03.SIHUAN PHARM (00460): ANNOUCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 20201
11.03.SIHUAN PHARM (00460): NOTICE OF BOARD MEETING2
26.02.SIHUAN PHARM (00460): VOLUNTARY ANNOUNCEMENT THE GROUP'S LIRAGLUTIDE HAS COMPLETED PHASE I CLINICAL STUDY FOR INDICATION OF WEIGHT LOSS3
17.02.Guotai Junan lifts Sihuan Pharmaceutical (00460) to HK$2.7811
10.02.SIHUAN PHARM (00460): VOLUNTARY ANNOUNCEMENT-APPROVAL TO LAUNCH THE GROUP'S EXCLUSIVE KOREAN BOTULINUM TOXIN PRODUCT "LETYBO 50U" IN THE PRC MARKET3
08.02.SIHUAN PHARM (00460): VOLUNTARY ANNOUNCEMENT - THE GROUP IS THE FIRST ENTERPRISE WITH ITS OCTREOTIDE ACETATE INJECTION PASSING THE CONSISTENCY EVALUATION2
03.02.SIHUAN PHARM (00460): VOLUNTARY ANNOUNCEMENT - PANTOPRAZOLE SODIUM INJECTION AND IBUPROFEN INJECTION OF THE GROUP ARE INCLUDED IN THE FOURTH BATCH OF NATIONAL DRUG CENTRALIZED PROCUREMENT LIST2
29.01.SIHUAN PHARM (00460): VOLUNTARY ANNOUNCEMENT - XUANZHU BIOPHARM'S MEDICAL PRODUCTS FOR THE TREATMENT OF NONALCOHOLIC STEATOHEPATITIS OBTAINED APPROVAL FOR CLINICAL TRIALS3
29.01.SIHUAN PHARM (00460): RESIGNATION OF EXECUTIVE DIRECTOR2
29.01.SIHUAN PHARM (00460): VOLUNTARY ANNOUNCEMENT - STRATEGIC INVESTMENT IN SHENZHEN MILEBOT ROBOTICS CO., LTD.3
27.01.SIHUAN PHARM (00460): VOLUNTARY ANNOUNCEMENT-CINEPAZIDE MALEATE INJECTION (KELINAO) OF SIHUAN PHARMACEUTICAL OBTAINED APPROVAL FOR NEW INDICATION3
27.01.SIHUAN PHARM (00460): VOLUNTARY ANNOUNCEMENT ACQUISITION OF JILIN AOTONG CHEMICAL CO., LTD. AND JILIN JIAHUI CHEMICAL CO., LTD.3
Seite:  Weiter >>
28 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1